Transcatheter Pulmonary Valve Market Is Predicted To Grow Quickly Due To The Increasing Demand For Pulmonary Valve Replacement Till 2025: Grand View Research, Inc.
The global transcatheter pulmonary valve market is expected
to reach a value of USD 54.1 million by 2025, according to a new report by
Grand View Research, Inc. The technological advancements pertaining to heart
valve technologies, and increasing number of clinical trials pipeline by
various public and private players are some of the crucial factors expected to
boost the market over the forecast period.
In 2015, North America held the
majority of market share of nearly 80.6% in the global market. Some of the
major drivers are increasing prevalence of the various cardiovascular
disorders, growing geriatric population with heart valve diseases such as pulmonary
stenosis, pulmonary regurgitation, and others, and rising awareness regarding
the benefits of transcatheter valves over surgical procedures. The growing
number of patients suffering from long-term heart disorders, rising awareness
about technologically advanced heart valve, and increasing healthcare
expenditures and reimbursement policies for overall transcatheter valves are
some of the key contributors to the growth of the market globally.
However, Asia Pacific is expected
to show a growth in this market after 2019, as there will be several product
launch in this region. The Asia Pacific region is expected to grow at a
lucrative growth rate owing to the growth of many developing economies like
Japan and China. These developing countries show a potential of growth due to
various contributors such as the increasing aging population and growing
prevalence of heart diseases. Moreover, the presence of a large pool of
patients, developing healthcare infrastructure & services, increasing
disposable income, and rising government funding are some of the factors that
are expected to drive the market during the forecast period.
Browse full research report on Transcatheter Pulmonary
Valve Market: http://www.grandviewresearch.com/industry-analysis/transcatheter-pulmonary-valve-market
Further key findings from
the study suggest:
- In 2015, tetralogy of Fallot (ToF) was the largest
application segment, owing to the growing prevalence of ToF and the presence
of huge product portfolio
- In 2015, balloon transcatheter valve segment held
majority of the revenue share and is expected to be the fastest growing
market during the forecast period
- The presence of huge patient base and growing
interest among the private and public players to launch product after the
completion of clinical trial in 2017 is expected to drive the Asia Pacific
market
- Some of the key players are Boston Scientific
Corporation, Braile Biomédica, Direct Flow Medical, Edwards Lifesciences
Corporation, JenaValve Technology, Inc., St. Jude Medical, SYMETIS,
Colibri Heart Valve, LLC, VENUS MEDTECH, and XELTIS.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the transcatheter
pulmonary valve market by application, technology, end-use, raw material, and
region:
Transcatheter Pulmonary Valve Application Outlook
(Revenue in USD Million, 2014 - 2025)
- Cardiac
Anomaly
- Pulmonary
Atresia
- Pulmonary
Stenosis
- Pulmonary
Regurgitation
- Tetralogy
of Fallot
- Truncus
Arteriosus
- Others
Transcatheter Pulmonary Valve Technology Outlook (Revenue
in USD Million, 2014 - 2025)
- Balloon-Expanded
Transcatheter Valve
- Self-Expanded
Transcatheter Valve
Transcatheter Pulmonary Valve End-Use Outlook (Revenue in
USD Million, 2014 - 2025)
- Adult
- Pediatric
Transcatheter Pulmonary Valve Raw Material Outlook
(Revenue in USD Million, 2014 - 2025)
- Synthetic
Transcatheter Valve
- Tissue
Engineered Transcatheter Valve
Transcatheter Pulmonary Valve Regional Outlook (Revenue
in USD Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Spain
- Russia
- France
- Italy
- Asia
Pacific
- China
- Japan
- Hong
Kong
- Taiwan
- Latin
America
- Mexico
- Brazil
- MEA
- South
Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment